[go: up one dir, main page]

RO86638B1 - Radioopaque medicine composition - Google Patents

Radioopaque medicine composition

Info

Publication number
RO86638B1
RO86638B1 RO111722A RO11172283A RO86638B1 RO 86638 B1 RO86638 B1 RO 86638B1 RO 111722 A RO111722 A RO 111722A RO 11172283 A RO11172283 A RO 11172283A RO 86638 B1 RO86638 B1 RO 86638B1
Authority
RO
Romania
Prior art keywords
radioopaque
medicine composition
tween
sorbitol
dispersed
Prior art date
Application number
RO111722A
Other languages
Romanian (ro)
Other versions
RO86638A2 (en
Inventor
Antoaneta Voiculescu
Constantin Paun
Alexandru Chirita
Natalia Radulescu
Eugenia Pascu
Sanda Morariu
Original Assignee
Institutul De Cercetari Chimico-Farmaceutice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul De Cercetari Chimico-Farmaceutice filed Critical Institutul De Cercetari Chimico-Farmaceutice
Priority to RO111722A priority Critical patent/RO86638B1/en
Publication of RO86638A2 publication Critical patent/RO86638A2/en
Publication of RO86638B1 publication Critical patent/RO86638B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Compozitia medicamentoasa radioopaca, conform inventiei, este constituita din 85...95% sulfat de bariu, 0,5...2p alginat de sodiu 5...15 p sorbitol, 0,2...0,9 p tween 80, 0,1...0,3 p ulei de menta, doza de administrare pentru o data fiind de 135 p pulbere care se disperseaza în 300 ml apa si serveste la explorarea radiologica a mucoasei tubului digestiv.The radiopaque drug composition of the invention consists of 85 ... 95% barium sulfate, 0.5 ... 2p sodium alginate 5 ... 15p sorbitol, 0.2 ... 0.9p tween 80 , 0.1 ... 0.3 p peppermint oil, the administration dose for a 135 pound powder that is dispersed in 300 ml of water and serves for the radiological exploration of the digestive tract mucosa.

RO111722A 1983-07-26 1983-07-26 Radioopaque medicine composition RO86638B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO111722A RO86638B1 (en) 1983-07-26 1983-07-26 Radioopaque medicine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO111722A RO86638B1 (en) 1983-07-26 1983-07-26 Radioopaque medicine composition

Publications (2)

Publication Number Publication Date
RO86638A2 RO86638A2 (en) 1985-04-17
RO86638B1 true RO86638B1 (en) 1985-05-01

Family

ID=20113460

Family Applications (1)

Application Number Title Priority Date Filing Date
RO111722A RO86638B1 (en) 1983-07-26 1983-07-26 Radioopaque medicine composition

Country Status (1)

Country Link
RO (1) RO86638B1 (en)

Also Published As

Publication number Publication date
RO86638A2 (en) 1985-04-17

Similar Documents

Publication Publication Date Title
GB8721186D0 (en) Pharmaceutical formulation
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
GB2103622B (en) Production of foot and mouth disease vaccine from microbially expressed antigens
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
HUP9801414A2 (en) Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
SE8404808L (en) MICROCAPCLE PLATE MEDICINE IN SOT MATRIX
US3621094A (en) Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts
Miller et al. Observations of pressure waves in stomach, jejunal, and colonic loops used to replace the esophagus
NO910080L (en) SWELLABLE DOSAGE UNITS INCLUDING COLLOIDAL VISMUT SUBSITRATE.
RO86638B1 (en) Radioopaque medicine composition
HK94096A (en) The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis
GB2153225A (en) Effervescent preparations containing diphosphonates
SE8705136D0 (en) ORAL DOSAGE UNIT FOR MEDICINAL PRODUCTS AND ITS USE AND PREPARATION
ES8707111A1 (en) Pharmaceutical preparation for the therapeutic treatment of rheumatic diseases
SE8704436D0 (en) USE OF ANTI-SECRETARY SUBSTANCES FOR NEW INDICATIONS
DK102788A (en) QUINOL COMPOUND AND ITS PHARMACEUTICAL USE
ATE13488T1 (en) GALLIUM CHLORIDE, A NEW ANTI-CANCER AGENT.
Ruffin et al. Role of anticholinergic drugs in treatment of peptic ulcer
IL65493A0 (en) Phenethanolamine derivatives,their preparation and pharmaceutical compositions containing them
ZA937876B (en) Oral medicament form
NO164958C (en) PROCEDURE FOR THE PREPARATION OF DIPYRIDAMOL PREPARATIONS WITH PH-INDEPENDENT, REGULATED RELEASE.
US5128141A (en) Association of physiologically dosed vitamin a and of various active principles having a therapeutical activity
DE3164054D1 (en) Pharmaceutically acceptable salts of 4'-(9-acridinylamino) methanesulfon-m-anisidide, their production, and pharmaceutical compositions containing such salts
Mäkelä et al. Effect of glucagon on the double contrast examination of the stomach and duodenum
Schreiner et al. CANCER of the tongue is one of the